154 related articles for article (PubMed ID: 2173504)
1. GABAmimetics diminish antinociception of meperidine under conditions which enhance other opioid mu-agonists.
Wynn RL; Bergman SA; Rudo FG; Leventer M
Arch Int Pharmacodyn Ther; 1990; 304():136-46. PubMed ID: 2173504
[TBL] [Abstract][Full Text] [Related]
2. Diazepam enhances fentanyl and diminishes meperidine antinociception.
Bergman SA; Wyn RL; Williams G
Anesth Prog; 1988; 35(5):190-4. PubMed ID: 3250278
[TBL] [Abstract][Full Text] [Related]
3. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
[TBL] [Abstract][Full Text] [Related]
4. Antinociceptive activity of pentamorphone, a 14-beta-aminomorphinone derivative, compared to fentanyl and morphine.
Rudo FG; Wynn RL; Ossipov M; Ford RD; Kutcher BA; Carter A; Spaulding TC
Anesth Analg; 1989 Oct; 69(4):450-6. PubMed ID: 2476953
[TBL] [Abstract][Full Text] [Related]
5. Assessment of relative intrinsic activity of mu-opioid analgesics in vivo by using beta-funaltrexamine.
Adams JU; Paronis CA; Holtzman SG
J Pharmacol Exp Ther; 1990 Dec; 255(3):1027-32. PubMed ID: 2175793
[TBL] [Abstract][Full Text] [Related]
6. Acute opioid pretreatment potentiates naltrexone-induced drinking suppression in water-deprived rats.
White DA; Holtzman SG
J Pharmacol Exp Ther; 2001 Jul; 298(1):156-64. PubMed ID: 11408537
[TBL] [Abstract][Full Text] [Related]
7. GABA and opioid mechanisms of the central amygdala underlie the withdrawal-potentiated startle from acute morphine.
Cabral A; Ruggiero RN; Nobre MJ; Brandão ML; Castilho VM
Prog Neuropsychopharmacol Biol Psychiatry; 2009 Mar; 33(2):334-44. PubMed ID: 19150477
[TBL] [Abstract][Full Text] [Related]
8. Relative potencies and durations of action with respect to respiratory depression of intravenous meperidine, fentanyl and alphaprodine in man.
Kaufman RD; Aqleh KA; Bellville JW
J Pharmacol Exp Ther; 1979 Jan; 208(1):73-9. PubMed ID: 759617
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive effects of ketamine-opioid combinations in the mouse tail flick test.
Dambisya YM; Lee TL
Methods Find Exp Clin Pharmacol; 1994 Apr; 16(3):179-84. PubMed ID: 8046951
[TBL] [Abstract][Full Text] [Related]
10. Pretreatment with pertussis toxin differentially modulates morphine- and beta-endorphin-induced antinociception in the mouse.
Tseng LF; Collins KA
J Pharmacol Exp Ther; 1996 Oct; 279(1):39-46. PubMed ID: 8858973
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein ATPase activating effect of opioid analgesics and their P-glycoprotein-dependent antinociception in mice.
Hamabe W; Maeda T; Fukazawa Y; Kumamoto K; Shang LQ; Yamamoto A; Yamamoto C; Tokuyama S; Kishioka S
Pharmacol Biochem Behav; 2006 Nov; 85(3):629-36. PubMed ID: 17134744
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive profiles of mu and kappa opioid agonists in a rat tooth pulp stimulation procedure.
Steinfels GF; Cook L
J Pharmacol Exp Ther; 1986 Jan; 236(1):111-7. PubMed ID: 2867210
[TBL] [Abstract][Full Text] [Related]
13. Interactions of NMDA antagonists and an alpha 2 agonist with mu, delta and kappa opioids in an acute nociception assay.
Baker AK; Hoffmann VL; Meert TF
Acta Anaesthesiol Belg; 2002; 53(3):203-12. PubMed ID: 12461830
[TBL] [Abstract][Full Text] [Related]
14. Involvement of mu-opioid receptors in antinociception and inhibition of gastrointestinal transit induced by 7-hydroxymitragynine, isolated from Thai herbal medicine Mitragyna speciosa.
Matsumoto K; Hatori Y; Murayama T; Tashima K; Wongseripipatana S; Misawa K; Kitajima M; Takayama H; Horie S
Eur J Pharmacol; 2006 Nov; 549(1-3):63-70. PubMed ID: 16978601
[TBL] [Abstract][Full Text] [Related]
15. Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.
Cichewicz DL; Martin ZL; Smith FL; Welch SP
J Pharmacol Exp Ther; 1999 May; 289(2):859-67. PubMed ID: 10215664
[TBL] [Abstract][Full Text] [Related]
16. Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.
Xu JY; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1992 Oct; 263(1):246-52. PubMed ID: 1328609
[TBL] [Abstract][Full Text] [Related]
17. Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice.
Roerig SC; Hoffman RG; Takemori AE; Wilcox GL; Fujimoto JM
J Pharmacol Exp Ther; 1991 Jun; 257(3):1091-9. PubMed ID: 1646321
[TBL] [Abstract][Full Text] [Related]
18. DPI-3290 [(+)-3-((alpha-R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide]. II. A mixed opioid agonist with potent antinociceptive activity and limited effects on respiratory function.
Gengo PJ; Pettit HO; O'Neill SJ; Su YF; McNutt R; Chang KJ
J Pharmacol Exp Ther; 2003 Dec; 307(3):1227-33. PubMed ID: 14534367
[TBL] [Abstract][Full Text] [Related]
19. An isobolographic analysis of the antinociceptive effect of systemically and intrathecally administered combinations of clonidine and opiates.
Ossipov MH; Harris S; Lloyd P; Messineo E
J Pharmacol Exp Ther; 1990 Dec; 255(3):1107-16. PubMed ID: 2262895
[TBL] [Abstract][Full Text] [Related]
20. Involvement of GABAergic modulation of the nucleus submedius (Sm) morphine-induced antinociception.
Jia H; Xie YF; Xiao DQ; Tang JS
Pain; 2004 Mar; 108(1-2):28-35. PubMed ID: 15109504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
